Twist Bioscience: Q4 Earnings Insights
Portfolio Pulse from Benzinga Insights
Twist Bioscience (NASDAQ:TWST) reported Q4 earnings with an EPS of $-0.81, beating estimates by 11.96% against an expected $-0.92. Revenue increased by $9.64 million compared to the same period last year. The company had previously beaten EPS estimates last quarter, which resulted in an 11.18% share price increase the following day.
November 17, 2023 | 12:35 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Twist Bioscience reported a better-than-expected Q4 EPS of $-0.81 and an increase in revenue, indicating potential positive investor sentiment and possible share price increase.
Given that Twist Bioscience exceeded earnings expectations and has a history of stock price increase following positive earnings reports, it is likely that the stock will experience short-term positive movement. However, the overall market conditions and sector performance also play a role in the stock's movement.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100